Stockscreener 앱 받기
15.30
1.29%
-0.20
시장 영업 전:
15.30
전일 마감가:
$15.50
열려 있는:
$15.62
하루 거래량:
133.61K
Relative Volume:
0.10
시가총액:
$121.72M
수익:
$49.09M
순이익/손실:
$-52.15M
주가수익비율:
-23.54
EPS:
-0.65
순현금흐름:
$-45.93M
1주 성능:
+18.33%
1개월 성능:
+48.54%
6개월 성능:
+72.57%
1년 성능:
+6.25%
1일 변동 폭
$14.61
$15.87
1주일 범위
$12.36
$17.40
52주 변동 폭
$3.436
$19.13
바이오데식스 Stock (BDSX) Company Profile
명칭
Biodesix Inc
전화
303-417-0500
주소
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
15.30 | 123.31M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
512.69 | 190.90B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.73 | 144.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
648.70 | 50.60B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.54 | 33.67B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.04 | 30.62B | 3.17B | 642.63M | 516.49M | 10.77 |
바이오데식스 Stock (BDSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-07-26 | 개시 | Craig Hallum | Buy |
| 2024-05-13 | 개시 | TD Cowen | Buy |
| 2024-05-03 | 개시 | Lake Street | Buy |
| 2021-11-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | 개시 | BTIG Research | Buy |
| 2020-11-23 | 개시 | Canaccord Genuity | Buy |
| 2020-11-23 | 개시 | Morgan Stanley | Overweight |
| 2020-11-23 | 개시 | William Blair | Outperform |
모두보기
바이오데식스 주식(BDSX)의 최신 뉴스
Wall Street experts predict that Biodesix (BDSX) may climb by 111.62%: Consider this information before making an investment decision - Bitget
Wall Street Analysts Think Biodesix (BDSX) Could Surge 111.62%: Read This Before Placing a Bet - Finviz
Are Medical Stocks Lagging Biodesix (BDSX) This Year? - Yahoo Finance
BDSX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Monashee Investment Management Cuts Biodesix Stake by 95% - National Today
Are healthcare stocks underperforming Biodesix (BDSX) so far this year? - Bitget
Canaccord reiterates Biodesix stock rating on strong Q4 results - Investing.com
Canaccord reiterates Biodesix stock rating on strong Q4 results By Investing.com - Investing.com UK
Biodesix (BDSX) Q4 2025 Earnings Call Transcript - AOL.com
Monashee Investment Management LLC Cuts Holdings in Biodesix, Inc. $BDSX - MarketBeat
Q4 2025 Biodesix Inc Earnings Call Transcript - GuruFocus
William Blair Upgrades Biodesix (BDSX) - Nasdaq
William Blair Upgrades BDSX (Biodesix, Inc.) to Outperform Feb 2026 - Meyka
Biodesix (NASDAQ:BDSX) Announces Quarterly Earnings Results, Beats Estimates By $0.56 EPS - MarketBeat
William Blair Upgrades Biodesix (BDSX) to 'Outperform' | BDSX St - GuruFocus
Biodesix expects 2026 sales to crack $100M - BizWest
Biodesix, Inc. (BDSX) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
William Blair Upgrades Biodesix to Outperform From Market Perform - marketscreener.com
GSA Capital Partners LLP Has $365,000 Stake in Biodesix, Inc. $BDSX - MarketBeat
William Blair upgrades Biodesix stock rating on execution momentum By Investing.com - Investing.com Australia
William Blair upgrades Biodesix stock rating on execution momentum - Investing.com India
Biodesix Inc (BDSX) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
Biodesix, Inc. Q4 Loss Drops - Nasdaq
Biodesix Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Biodesix Q4 2025 shows strong revenue growth and positive EBITDA - Investing.com Nigeria
BDSX Projects 80% Gross Margin and Revenue Growth for FY26 - GuruFocus
Biodesix Inc (NASDAQ:BDSX) Reports Q4 2025 Earnings Beat and First Adjusted EBITDA Profitability - ChartMill
Biodesix Q4 Earnings Call Highlights - MarketBeat
Biodesix (BDSX) Surpasses Revenue Expectations in Q4 with 41% Gr - GuruFocus
Biodesix, Inc. (BDSX) Reports Q4 Loss, Beats Revenue Estimates - Nasdaq
Biodesix Inc. (BDSX) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Biodesix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights - TradingView
Biodesix (NASDAQ: BDSX) hits first positive EBITDA on 41% Q4 growth - Stock Titan
BRIEF-Biodesix Q4 Adjusted Operating Expenses USD 25.8 Million - TradingView
Biodesix, Inc. (BDSX) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
Earnings To Watch: Biodesix Inc (BDSX) Reports Q4 2025 Result - GuruFocus
Biodesix to Participate in Upcoming Investor Conferences - Caledonian Record
Biodesix management to speak at TD Cowen and Barclays events - Stock Titan
Insider Selling: Biodesix (NASDAQ:BDSX) CEO Sells 1,490 Shares of Stock - MarketBeat
Biodesix officer Pestano sells $7103 in BDSX stock By Investing.com - Investing.com Australia
O’Kane, Biodesix CCO, sells $6834 in BDSX stock - Investing.com South Africa
O’Kane, Biodesix CCO, sells $6834 in BDSX stock By Investing.com - Investing.com Canada
Cowie, Biodesix CFO, sells $6834 in BDSX stock - Investing.com
Biodesix officer Pestano sells $7103 in BDSX stock - Investing.com
Tax-driven Biodesix (BDSX) insider trades follow RSU vesting events - Stock Titan
Biodesix (NASDAQ: BDSX) CDO acquires RSU shares, sells some for taxes - Stock Titan
Telemark Asset Management LLC Trims Position in Biodesix, Inc. $BDSX - MarketBeat
Can Biodesix Inc. stock sustain market leadershipTrade Risk Report & Free Fast Entry Momentum Trade Alerts - mfd.ru
Can Biodesix Inc. expand into new marketsBull Run & High Conviction Trade Alerts - mfd.ru
Earnings Miss: How volatile is FBRTPRE stockTrade Analysis Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn
바이오데식스 (BDSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.04%
0.76%
자본화:
|
볼륨(24시간):